作者
Yasmin Abaza,Hagop M. Kantarjian,Guillermo Garcia‐Manero,Elihu Estey,Gautam Borthakur,Elias Jabbour,Stefan Faderl,Susan O’Brien,William G. Wierda,Sherry Pierce,Mark Brandt,Deborah McCue,Rajyalakshmi Luthra,Keyur P. Patel,Steven M. Kornblau,Tapan M. Kadia,Courtney D. DiNardo,Nitin Jain,Srđan Verstovšek,Alessandra Ferrajoli,Michael Andreeff,Marina Konopleva,Zeev Estrov,Maria Cielo Foudray,David McCue,Jorge Cortes,Farhad Ravandi
摘要
Key Points The combination of ATRA and ATO, with or without GO, is effective and safe for newly diagnosed APL patients, including the high-risk subset. Long-term follow-up suggests the responses are durable, with very rare relapses.